| 1. |
Sur V.P.♦, Mazumdar A.♦, Vimberg V.♦, Stefani T.♦, Androvic L.♦, Kracikova L.♦, Laga R.♦, Kamenik Z.♦, Komrskova K.♦, Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics,
International Journal of Molecular Sciences, ISSN: 1422-0067, DOI: 10.3390/ijms23010097, Vol.23, No.1, pp.97-1-17, 2022 Abstract: Teicoplanin is a natural lipoglycopeptide antibiotic with a similar activity spectrum as vancomycin; however, it has with the added benefit to the patient of low cytotoxicity. Both teicoplanin and vancomycin antibiotics are actively used in medical practice in the prophylaxis and treatment of severe life-threatening infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, Enterococcus faecium and Clostridium difficile. The expression of vancomycin Z (vanZ), encoded either in the vancomycin A (vanA) glycopeptide antibiotic resistance gene cluster or in the genomes of E. faecium, as well as Streptococcus pneumoniae and C. difficile, was shown to specifically compromise the antibiotic efficiency through the inhibition of teicoplanin binding to the bacterial surface. However, the exact mechanisms of this action and protein structure remain unknown. In this study, the three-dimensional structure of VanZ from E. faecium EnGen0191 was predicted by using the I-TASSER web server. Based on the VanZ structure, a benzimidazole based ligand was predicted to bind to the VanZ by molecular docking. Importantly, this new ligand, named G3K, was further confirmed to specifically inhibit VanZ-mediated resistance to teicoplanin in vivo. Keywords: antibiotic resistance, benzimidazole, docking, Enterococcus faecium, ligands, lipoglycopeptide antibiotic, MD simulation, Staphylococcus aureus, teicoplanin VanZ Affiliations:
| Sur V.P. | - | other affiliation | | Mazumdar A. | - | other affiliation | | Vimberg V. | - | other affiliation | | Stefani T. | - | other affiliation | | Androvic L. | - | other affiliation | | Kracikova L. | - | other affiliation | | Laga R. | - | other affiliation | | Kamenik Z. | - | other affiliation | | Komrskova K. | - | other affiliation |
|  |
| 2. |
Sur V.♦, Simonik O.♦, Novotna M.♦, Mazumdar A.♦, Liska F.♦, Vimberg V.♦, Komrskova K.♦, Dynamic study of small toxic hydrophobic proteins PepA1 and PepG1 of Staphylococcus aureus,
International Journal of Biological Macromolecules, ISSN: 0141-8130, DOI: 10.1016/j.ijbiomac.2022.07.192, Vol.219, pp.1360-1371, 2022 Abstract: Toxin-antitoxin (TA) systems are small genetic elements which encode toxin proteins that interfere with vital cellular functions. PepA1 and PepG1 toxin proteins, known also as SprA1 and SprG1, are type I TA. In Staphylococcus aureus (S. aureus), their expression without the antitoxin counterparts (SprA1AS and SprF1), is lethal to the pathogen. Molecular Dynamics (MD) simulation was performed for PepA1 and PepG1 to understand their dynamic state, conformational changes, and their toxicity. The protein structures were constructed and used for MD simulation and the conformational changes, stability, flexibility, fluctuations, hydrophobicity, and role of their dynamic state on function prediction were studied extensively by GROMACS MD simulation analysis tools. In silico study indicated that the PepA1 and PepG1 proteins change their structural conformation from an open to closed state where PepA1 conformational changes were faster (10 ns) than PepG1 (20 ns) while PepG1 exerted more stability and flexibility than PepA1. According to SASA values, PepG1 is more hydrophobic than the PepA1 and forms fewer hydrogen bonds than PepA1. The in vivo study with PepA1 and PepG1 proteins provided evidence that both the conformation changes between the open and closed states and the amino acid sequence are crucial for peptide toxicity. Keywords: Toxin-antitoxin system, Staphylococcus aureus, PepA1, PepG1, Molecular dynamics simulation, Cloning Affiliations:
| Sur V. | - | other affiliation | | Simonik O. | - | other affiliation | | Novotna M. | - | other affiliation | | Mazumdar A. | - | other affiliation | | Liska F. | - | other affiliation | | Vimberg V. | - | other affiliation | | Komrskova K. | - | other affiliation |
|  |